Buparlisib, a PI3K inhibitor, demonstrates acceptable tolerability and preliminary activity in a phase I trial of patients with advanced leukemias
| Image |  |
|---|---|
| Description | scientific article published on 27 September 2016 |
| Author/s |
author: Elias Jabbour William G Wierda Gautam Borthakur Guillermo Garcia-Manero Michael Andreeff Naval Daver Steven M Kornblau Jorge Eduardo Cortes Jan A Burger Brittany Knick Ragon Courtney D DiNardo Hagop Kantarjian Marina Konopleva Naveen Pemmaraju Zhihong Zeng Farhad Ravandi |
| Publication date | September 27, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |